Myeloproliferative Neoplasms in Children

Area of Science:

• Hematology
• Pediatric Oncology
• Molecular Diagnostics

Background:

• Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders.
• Classical BCR-ABL-negative MPNs include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
• MPNs are rare in children, and common adult mutations (JAK2, MPL, CALR) are infrequent, complicating pediatric diagnosis.

Purpose of the Study:

• To review the clinical presentation, diagnosis, differential diagnosis, treatment, and prognosis of BCR-ABL-negative MPNs in children.
• To highlight key differences between pediatric and adult MPNs.
• To focus on pediatric primary myelofibrosis (PMF) as a unique entity.

Main Methods:

• Review of existing literature on pediatric MPNs.
• Analysis of diagnostic criteria and challenges in the pediatric population.
• Comparison of pediatric MPN characteristics with adult counterparts.

Main Results:

• Pediatric MPN diagnosis relies heavily on clinical and laboratory findings due to rare driver mutations.
• Pediatric primary myelofibrosis (PMF) presents unique features compared to adult PMF.
• Significant differences exist in presentation, diagnosis, and potentially treatment between pediatric and adult MPNs.

Conclusions:

• Accurate diagnosis of pediatric MPNs requires careful clinical evaluation and exclusion of secondary causes.
• Pediatric MPNs, particularly PMF, represent distinct disease entities requiring tailored approaches.
• Further research is needed to elucidate unique aspects of MPNs in children.